ElastiMed Welcomes Dr. Amir Belson to Its Board of Directors
ElastiMed Ltd., a pioneering company in the realm of wearable medical devices, recently announced a significant addition to its leadership team with the appointment of Dr. Amir Belson as a member of its Board of Directors. This critical move is set to drive the company’s mission to innovate patient care through cutting-edge technology.
Dr. Amir Belson: A Wealth of Experience
Dr. Belson is a well-respected leader in the medical device landscape, known for his extensive expertise in guiding healthcare companies through the challenging phases of development and commercialization. His remarkable journey includes founding Neoguide Systems, a company specializing in robotic endoscopy, which was successfully acquired by Intuitive Surgical in 2009. Additionally, he played a pivotal role in founding Vascular Pathways, which focused on vascular intervention and was acquired by C.R. Bard in 2014, as well as Zipline Medical, a wound closure company that joined the ranks of Stryker in 2019.
Innovative Contributions to Medical Technology
Dr. Belson has not only founded these transformative companies but has also established other significant ventures like Venocare, Radiaction Medical, Emboline, Follisave, and Modular Surgical. His entrepreneurial spirit and commitment to innovation make him an invaluable asset to ElastiMed’s Board.
Vision for ElastiMed's Future
Expressing his enthusiasm about his new role, Dr. Belson stated, "I am honored to join ElastiMed as a member of the Board. ElastiMed is by far the most innovative company in the compression therapy arena. Their wearable medical devices will bring relief to tens of millions of lymphatic and venous disease sufferers around the world."
He emphasized the importance of empowering patients to engage fully in their lives without the limitations imposed by their medical conditions. Dr. Belson is eager to collaborate with the talented team at ElastiMed to propel future innovations and deliver impactful solutions.
Key Factors for Growth
ElastiMed is poised for significant advancements as it prepares to launch its wearable medical devices to the market. The integration of Dr. Belson's vast experience in leadership and successful entrepreneurship is expected to guide the company effectively through this pivotal stage of growth.
Company Leadership Insights
Omer Zelka, the Founder and CEO of ElastiMed, shared his perspective on Dr. Belson’s appointment: "We are thrilled to welcome Dr. Belson to ElastiMed's Board. Amir's expertise will be instrumental as we continue to advance our mission of revolutionizing care at home for lymphedema and venous disease patients through wearable technology."
Zelka highlighted Dr. Belson's well-recognized contributions to the medical device industry and his dedication to improving patient outcomes, stating that his vision aligns perfectly with ElastiMed's values and goals.
About ElastiMed
ElastiMed's innovations are centered around wearable medical devices designed specifically for treating and managing lymphatic and venous diseases. The company's commitment to excellence and patient-centric solutions empowers both patients and healthcare providers, enhancing the quality of care available at home.
As a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY), ElastiMed has also secured funding from various notable organizations, including the Israeli Innovation Authority and Horizon 2020, as well as private investors.
Contact Information
Interested parties can learn more about ElastiMed and its innovative medical solutions by visiting the official website. The company’s dedication to advancing healthcare technology is unwavering, and it invites all to engage with its mission to deliver enhanced patient care.
Frequently Asked Questions
Who is Dr. Amir Belson?
Dr. Amir Belson is a seasoned leader in the medical device industry with a history of founding successful companies and guiding them to acquisition.
What is ElastiMed's mission?
ElastiMed aims to revolutionize care for patients with lymphatic and venous diseases through innovative wearable medical devices.
How does Dr. Belson plan to contribute at ElastiMed?
Dr. Belson intends to leverage his extensive experience to drive innovation and improve patient solutions at ElastiMed.
What types of diseases do ElastiMed products target?
ElastiMed focuses on treating and managing lymphatic and venous diseases with its cutting-edge wearable technology.
What funding support has ElastiMed received?
ElastiMed has obtained funding from the Israeli Innovation Authority, Horizon 2020, and various private investors, facilitating its growth in medical innovation.
